The global microbial fermentation technology market size is expected to reach USD 49.39 billion by 2030, registering a CAGR of 5.8%. Since fermentation is observed to be of utmost importance in the manufacturing of biopharmaceuticals, there is also a growing demand for microbial fermentation technology in biopharmaceutical manufacturing. This has led to increasing collaborations and developments in this market space.
For instance, in September 2021, BIOVECTRA and ABEC collaboratively announced that the latter company would provide CSR single-use microbial fermentation solutions to expand BIOVECTRA’s manufacturing capabilities. The newly installed solutions are expected to provide a faster turnaround time with high-growth microbial fermentation on large scale. Moreover, in September 2022, Cargill and Genomatica along with Cyclone Engineers are working on a project to scale up the bioreactor fermentation processing. This project is a part of the National Biotechnology and Biomanufacturing Initiative with a grant of USD 2.5 million.
Furthermore, technological advances in microbial fermentation platforms are also expected to supplement the market growth. For instance, several metabolic engineering approaches have been developed by researchers to enhance the performance of microbial cell factories used for the production of complex biologics or small molecules. Such continuous developments in this market space are likely to increase the adoption of this technology in biomanufacturing.
Additionally, various medications and vaccines, such as hormones, antibody fragments, and pneumococcal vaccines, are bio-manufactured using microbial fermentation techniques. Bacterial cells are often resistant to shear damage, enabling the use of high-shear radial impeller systems and high agitation rates. This gives the fermentors a high mass transfer potential, allowing them to accommodate fast metabolizing, high-cell density microbial cell cultivations and increasing the quantity of product that the bioprocesses can produce. Thus, with the increasing adoption of SUB fermentors for bacterial fermentation, the market is likely to witness significant growth in the coming years.
This product will be delivered within 1-3 business days.
For instance, in September 2021, BIOVECTRA and ABEC collaboratively announced that the latter company would provide CSR single-use microbial fermentation solutions to expand BIOVECTRA’s manufacturing capabilities. The newly installed solutions are expected to provide a faster turnaround time with high-growth microbial fermentation on large scale. Moreover, in September 2022, Cargill and Genomatica along with Cyclone Engineers are working on a project to scale up the bioreactor fermentation processing. This project is a part of the National Biotechnology and Biomanufacturing Initiative with a grant of USD 2.5 million.
Furthermore, technological advances in microbial fermentation platforms are also expected to supplement the market growth. For instance, several metabolic engineering approaches have been developed by researchers to enhance the performance of microbial cell factories used for the production of complex biologics or small molecules. Such continuous developments in this market space are likely to increase the adoption of this technology in biomanufacturing.
Additionally, various medications and vaccines, such as hormones, antibody fragments, and pneumococcal vaccines, are bio-manufactured using microbial fermentation techniques. Bacterial cells are often resistant to shear damage, enabling the use of high-shear radial impeller systems and high agitation rates. This gives the fermentors a high mass transfer potential, allowing them to accommodate fast metabolizing, high-cell density microbial cell cultivations and increasing the quantity of product that the bioprocesses can produce. Thus, with the increasing adoption of SUB fermentors for bacterial fermentation, the market is likely to witness significant growth in the coming years.
Microbial Fermentation Technology Market Report Highlights
- Based on application, the antibiotics segment captured the highest market revenue share in 2021. Increasing research activities due to the rise of antibiotic-resistant microbes have positively impacted market growth
- Owing to the faster and more stable growth pattern of microorganisms, the use of fermentation in small molecule synthesis is expected to witness lucrative growth throughout the forecast period
- By end-users, CMOs and CDMOs accounted for a significant share in 2021. The capacity expansion by several CMOs and the growing trend of outsourcing is expected to propel the segment revenue generation
- Asia Pacific dominated the market in 2021 owing to the high number of operating CMOs and the growing biopharmaceutical industry in countries such as India, Japan, and China
- Furthermore, the demand for biologics and biopharmaceuticals is increasing in Japan. As a result, Japanese firms are undertaking various strategic initiatives to enhance their domestic biomanufacturing operations
- North America is anticipated to witness the fastest growth throughout the forecast period owing to the presence of a well-established biopharmaceutical industry coupled with a high number of fermentation solution providers
- Continuous efforts by key players to improve their product offerings are also contributing to North America’s regional market growth
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope1.1. Information Procurement
1.2. Information or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing usage of fermentation technology-derived products among various industries
3.4.2. Rising research and development activities in different fields of fermentation technology
3.4.3. Exhausting fossil fuel reserves and rising gasoline prices
3.5. Market Restraint Analysis
3.5.1. Technological challenges associated with microbial fermentation
3.6. Penetration and Growth Prospect Mapping 2022
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis
Chapter 4. Application Business Analysis
4.1. Microbial Fermentation Technology Market: Product Movement Analysis
4.2. Antibiotics
4.2.1. Antibiotics Market, 2018 - 2030 (USD Million)
4.3. Probiotics Supplements
4.3.1. Probiotics Supplements Market, 2018 - 2030 (USD Million)
4.4. Monoclonal Antibodies
4.4.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Million)
4.5. Recombinant Proteins
4.5.1. Recombinant Proteins Market, 2018 - 2030 (USD Million)
4.6. Biosimilars
4.6.1. Biosimilars Market, 2018 - 2030 (USD Million)
4.7. Vaccines
4.7.1. Vaccines Market, 2018 - 2030 (USD Million)
4.8. Enzymes
4.8.1. Enzymes Market, 2018 - 2030 (USD Million)
4.9. Small Molecules
4.9.1. Small Molecules Market, 2018 - 2030 (USD Million)
4.10. Others
4.10.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. End-User Business Analysis
5.1. Microbial Fermentation Technology Market: End-User Movement Analysis
5.2. Biopharmaceutical Companies
5.2.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
5.3. Contract Research Organizations (CROs)
5.3.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)
5.4. CMOs & CDMOs
5.4.1. CMOs & CDMOs Market, 2018 - 2030 (USD Million)
5.5. Academic & Research Institutes
5.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Microbial Fermentation Technology Market Share By Region, 2022 & 2030
6.2. North America
6.2.1. SWOT Analysis
6.2.2. North America Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.2.3. U.S.
6.2.3.1. Key Country Dynamics
6.2.3.2. Target Disease Prevalence
6.2.3.3. Competitive Scenario
6.2.3.4. Regulatory Framework
6.2.3.5. U.S. Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.2.4. Canada
6.2.4.1. Key Country Dynamics
6.2.4.2. Target Disease Prevalence
6.2.4.3. Competitive Scenario
6.2.4.4. Regulatory Framework
6.2.4.5. Canada Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. SWOT Analysis
6.3.2. Europe Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Target Disease Prevalence
6.3.3.3. Competitive Scenario
6.3.3.4. Regulatory Framework
6.3.3.5. Germany Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.3.4. UK
6.3.4.1. Key Country Dynamics
6.3.4.2. Target Disease Prevalence
6.3.4.3. Competitive Scenario
6.3.4.4. Regulatory Framework
6.3.4.5. UK Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.3.5. France
6.3.5.1. Key Country Dynamics
6.3.5.2. Target Disease Prevalence
6.3.5.3. Competitive Scenario
6.3.5.4. Regulatory Framework
6.3.5.5. France Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.3.6. Italy
6.3.6.1. Key Country Dynamics
6.3.6.2. Target Disease Prevalence
6.3.6.3. Competitive Scenario
6.3.6.4. Regulatory Framework
6.3.6.5. Italy Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.3.7. Spain
6.3.7.1. Key Country Dynamics
6.3.7.2. Target Disease Prevalence
6.3.7.3. Competitive Scenario
6.3.7.4. Regulatory Framework
6.3.7.5. Spain Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.3.8. Denmark
6.3.8.1. Key Country Dynamics
6.3.8.2. Target Disease Prevalence
6.3.8.3. Competitive Scenario
6.3.8.4. Regulatory Framework
6.3.8.5. Denmark Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.3.9. Sweden
6.3.9.1. Key Country Dynamics
6.3.9.2. Target Disease Prevalence
6.3.9.3. Competitive Scenario
6.3.9.4. Regulatory Framework
6.3.9.5. Sweden Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.3.10. Norway
6.3.10.1. Key Country Dynamics
6.3.10.2. Target Disease Prevalence
6.3.10.3. Competitive Scenario
6.3.10.4. Regulatory Framework
6.3.10.5. Norway Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. SWOT Analysis
6.4.2. Asia Pacific Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Competitive Scenario
6.4.3.4. Regulatory Framework
6.4.3.5. Japan Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.4.4. China
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Competitive Scenario
6.4.4.4. Regulatory Framework
6.4.4.5. China Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.4.5. India
6.4.5.1. Key Country Dynamics
6.4.5.2. Target Disease Prevalence
6.4.5.3. Competitive Scenario
6.4.5.4. Regulatory Framework
6.4.5.5. India Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. Key Country Dynamics
6.4.6.2. Target Disease Prevalence
6.4.6.3. Competitive Scenario
6.4.6.4. Regulatory Framework
6.4.6.5. South Korea Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.4.7. Australia
6.4.7.1. Key Country Dynamics
6.4.7.2. Target Disease Prevalence
6.4.7.3. Competitive Scenario
6.4.7.4. Regulatory Framework
6.4.7.5. Australia Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.4.8. Thailand
6.4.8.1. Key Country Dynamics
6.4.8.2. Target Disease Prevalence
6.4.8.3. Competitive Scenario
6.4.8.4. Regulatory Framework
6.4.8.5. Thailand Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. SWOT Analysis
6.5.2. Latin America Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.5.3. Brazil
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Competitive Scenario
6.5.3.4. Regulatory Framework
6.5.3.5. Brazil Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Competitive Scenario
6.5.4.4. Regulatory Framework
6.5.4.5. Mexico Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.5.5. Argentina
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Competitive Scenario
6.5.5.4. Regulatory Framework
6.5.5.5. Argentina Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.6. MEA
6.6.1. SWOT Analysis
6.6.2. MEA Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.6.3. South Africa
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Competitive Scenario
6.6.3.4. Regulatory Framework
6.6.3.5. South Africa Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.6.4. Saudi Arabia
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Competitive Scenario
6.6.4.4. Regulatory Framework
6.6.4.5. Saudi Arabia Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.6.5. UAE
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Competitive Scenario
6.6.5.4. Regulatory Framework
6.6.5.5. UAE Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
6.6.6. Kuwait
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Competitive Scenario
6.6.6.4. Regulatory Framework
6.6.6.5. Kuwait Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Share Analysis, 2022
7.3. Strategy Mapping
7.3.1. Expansion
7.3.2. Acquisition
7.3.3. Collaborations
7.3.4. Product/Therapeutic Area Launch
7.3.5. Partnerships
7.3.6. Others
7.4. Participant’s overview
7.4.1. Biocon Ltd.
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. BioVectra Inc.
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Danone UK
7.4.3.1. Overview
7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. F. Hoffmann-La Roche AG
7.4.4.1. Overview
7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Koninklijke DSM NV
7.4.5.1. Overview
7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Lonza
7.4.6.1. Overview
7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Novozymes A/S
7.4.7.1. Overview
7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. TerraVia Holdings, Inc.
7.4.8.1. Overview
7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. BIOZEEN
7.4.9.1. Overview
7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
TABLE 2. List of Abbreviations
TABLE 3. Global microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 4. Global microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 5. Global microbial fermentation technology market, by Region, 2018 - 2030 (USD Million)
TABLE 6. North America microbial fermentation technology market, by Country, 2018 - 2030 (USD Million)
TABLE 7. North America microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 8. North America microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 9. U.S. microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 10. U.S. microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 11. Canada microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 12. Canada microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 13. Europe microbial fermentation technology market, by Country, 2018 - 2030 (USD Million)
TABLE 14. Europe microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 15. Europe microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 16. UK microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 17. UK microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 18. Germany microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 19. Germany microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 20. France microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 21. France microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 22. Italy microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 23. Italy microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 24. Spain microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 25. Spain microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 26. Denmark microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 27. Denmark microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 28. Sweden microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 29. Sweden microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 30. Norway microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 31. Norway microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 32. Asia Pacific microbial fermentation technology market, by Country, 2018 - 2030 (USD Million)
TABLE 33. Asia Pacific microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 34. Asia Pacific microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 35. Japan microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 36. Japan microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 37. China microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 38. China microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 39. India microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 40. India microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 41. Australia microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 42. Australia microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 43. Thailand microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 44. Thailand microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 45. South Korea microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 46. South Korea microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 47. Latin America microbial fermentation technology market, by Country, 2018 - 2030 (USD Million)
TABLE 48. Latin America microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 49. Latin America microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 50. Brazil microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 51. Brazil microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 52. Mexico microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 53. Mexico microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 54. Argentina microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 55. Argentina microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 56. Middle East and Africa microbial fermentation technology market, by Country, 2018 - 2030 (USD Million)
TABLE 57. Middle East and Africa microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 58. Middle East and Africa microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 59. South Africa microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 60. South Africa microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 61. Saudi Arabia microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 62. Saudi Arabia microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 63. UAE microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 64. UAE microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
TABLE 65. Kuwait microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
TABLE 66. Kuwait microbial fermentation technology market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Microbial Fermentation Technology Market Segmentation
FIG. 8 Market Snapshot, 2022
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2022
FIG. 16 Global Microbial Fermentation Technology Market: End-use Movement Analysis
FIG. 17 Global Microbial Fermentation Technology Market, for Bio-Pharmaceutical Companies, 2018 - 2030 (USD Million)
FIG. 18 Global Microbial Fermentation Technology Market, for Contract Research Organizations (CROs), 2018 - 2030 (USD Million)
FIG. 19 Global Microbial Fermentation Technology Market, for CMOs & CDMOs, 2018 - 2030 (USD Million)
FIG. 20 Global Microbial Fermentation Technology Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
FIG. 21 Global Microbial Fermentation Technology Market: Application Movement Analysis
FIG. 22 Global Microbial Fermentation Technology Market, for Antibiotics, 2018 - 2030 (USD Million)
FIG. 23 Global Microbial Fermentation Technology Market, for Probiotics Supplements, 2018 - 2030 (USD Million)
FIG. 24 Global Microbial Fermentation Technology Market, for Monoclonal Antibodies, 2018 - 2030 (USD Million)
FIG. 25 Global Microbial Fermentation Technology Market, for Recombinant Proteins, 2018 - 2030 (USD Million)
FIG. 26 Global Microbial Fermentation Technology Market, for Biosimilars, 2018 - 2030 (USD Million)
FIG. 27 Global Microbial Fermentation Technology Market, for Vaccines, 2018 - 2030 (USD Million)
FIG. 28 Global Microbial Fermentation Technology Market, for Enzymes, 2018 - 2030 (USD Million)
FIG. 29 Global Microbial Fermentation Technology Market, for Small Molecules, 2018 - 2030 (USD Million)
FIG. 30 Global Microbial Fermentation Technology Market, for Others, 2018 - 2030 (USD Million)
FIG. 31 Regional Marketplace: Key Takeaways
FIG. 32 Regional Outlook, 2022 & 2030
FIG. 33 Global Microbial Fermentation Technology Market: Region Movement Analysis
FIG. 34 North America Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 35 U.S. Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 36 Canada Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 37 Europe Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 38 UK Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 39 Germany Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 40 France Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 41 Italy Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 42 Spain Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 43 Denmark Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 44 Sweden Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 45 Norway Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 46 Asia Pacific Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 47 Japan Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 48 China Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 49 India Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 50 Australia Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 51 Thailand Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 52 South Korea Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 53 Latin America Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 54 Brazil Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 55 Mexico Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 56 Argentina Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 57 Middle East & Africa Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 58 South Africa Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 59 Saudi Arabia Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 60 UAE Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
FIG. 61 Kuwait Microbial Fermentation Technology Market, 2018 - 2030 (USD Million)
Companies Mentioned
- Biocon Ltd.
- BioVectra Inc.
- Danone UK
- F. Hoffmann-La Roche AG
- Koninklijke DSM NV
- Lonza
- Novozymes A/S
- TerraVia Holdings, Inc.
- BIOZEEN
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | March 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 30964.1 Million |
| Forecasted Market Value ( USD | $ 49390 Million |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
